These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 25385716)

  • 21. Biofabrication of a three-dimensional liver micro-organ as an in vitro drug metabolism model.
    Chang R; Emami K; Wu H; Sun W
    Biofabrication; 2010 Dec; 2(4):045004. PubMed ID: 21079286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JALA special issue: microengineered cell- and tissue-based assays for drug screening and toxicology applications.
    Huh DD; Kim DH
    J Lab Autom; 2015 Apr; 20(2):79-81. PubMed ID: 25795434
    [No Abstract]   [Full Text] [Related]  

  • 23. An integrated biomimetic array chip for establishment of collagen-based 3D primary human hepatocyte model for prediction of clinical drug-induced liver injury.
    Xiao RR; Lv T; Tu X; Li P; Wang T; Dong H; Tu P; Ai X
    Biotechnol Bioeng; 2021 Dec; 118(12):4687-4698. PubMed ID: 34478150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioengineered 3D Models to Recapitulate Tissue Fibrosis.
    Sacchi M; Bansal R; Rouwkema J
    Trends Biotechnol; 2020 Jun; 38(6):623-636. PubMed ID: 31952833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioengineering heart tissue for in vitro testing.
    Cimetta E; Godier-Furnémont A; Vunjak-Novakovic G
    Curr Opin Biotechnol; 2013 Oct; 24(5):926-32. PubMed ID: 23932513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent Advances on Cell Culture Platforms for In Vitro Drug Screening and Cell Therapies: From Conventional to Microfluidic Strategies.
    Cardoso BD; Castanheira EMS; Lanceros-Méndez S; Cardoso VF
    Adv Healthc Mater; 2023 Jul; 12(18):e2202936. PubMed ID: 36898671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-Dimensional and Three-Dimensional Cartilage Model Platforms for Drug Evaluation and High-Throughput Screening Assays.
    Foster NC; Hall NM; Haj AJE
    Tissue Eng Part B Rev; 2022 Apr; 28(2):421-436. PubMed ID: 34010074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved in vitro models for preclinical drug and formulation screening focusing on 2D and 3D skin and cornea constructs.
    Beißner N; Bolea Albero A; Füller J; Kellner T; Lauterboeck L; Liang J; Böl M; Glasmacher B; Müller-Goymann CC; Reichl S
    Eur J Pharm Biopharm; 2018 May; 126():57-66. PubMed ID: 29191717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model.
    Kunz-Schughart LA; Freyer JP; Hofstaedter F; Ebner R
    J Biomol Screen; 2004 Jun; 9(4):273-85. PubMed ID: 15191644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascularization Strategies in 3D Cell Culture Models: From Scaffold-Free Models to 3D Bioprinting.
    Anthon SG; Valente KP
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Micro-scaffold array chip for upgrading cell-based high-throughput drug testing to 3D using benchtop equipment.
    Li X; Zhang X; Zhao S; Wang J; Liu G; Du Y
    Lab Chip; 2014 Feb; 14(3):471-81. PubMed ID: 24287736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling the lung: Design and development of tissue engineered macro- and micro-physiologic lung models for research use.
    Nichols JE; Niles JA; Vega SP; Argueta LB; Eastaway A; Cortiella J
    Exp Biol Med (Maywood); 2014 Sep; 239(9):1135-69. PubMed ID: 24962174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microengineered 3D Tumor Models for Anti-Cancer Drug Discovery in Female-Related Cancers.
    Amirghasemi F; Adjei-Sowah E; Pockaj BA; Nikkhah M
    Ann Biomed Eng; 2021 Aug; 49(8):1943-1972. PubMed ID: 33403451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thinking inside the box: keeping tissue-engineered constructs in vitro for use as preclinical models.
    Gibbons MC; Foley MA; Cardinal KO
    Tissue Eng Part B Rev; 2013 Feb; 19(1):14-30. PubMed ID: 22800715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers for simplifying HTS 3D cell culture platforms for drug discovery: the case for cytokines.
    Lai Y; Asthana A; Kisaalita WS
    Drug Discov Today; 2011 Apr; 16(7-8):293-7. PubMed ID: 21277382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kidney-on-a-Chip: A New Technology for Predicting Drug Efficacy, Interactions, and Drug-induced Nephrotoxicity.
    Lee J; Kim S
    Curr Drug Metab; 2018; 19(7):577-583. PubMed ID: 29521220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-Throughput 3D Tumor Spheroid Screening Method for Cancer Drug Discovery Using Celigo Image Cytometry.
    Kessel S; Cribbes S; Déry O; Kuksin D; Sincoff E; Qiu J; Chan LL
    SLAS Technol; 2017 Aug; 22(4):454-465. PubMed ID: 27272155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting.
    Ma X; Qu X; Zhu W; Li YS; Yuan S; Zhang H; Liu J; Wang P; Lai CS; Zanella F; Feng GS; Sheikh F; Chien S; Chen S
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2206-11. PubMed ID: 26858399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical and biological advances in endothelial cell-based engineered co-culture model systems.
    Mierke CT
    Semin Cell Dev Biol; 2023 Sep; 147():58-69. PubMed ID: 36732105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening out irrelevant cell-based models of disease.
    Horvath P; Aulner N; Bickle M; Davies AM; Nery ED; Ebner D; Montoya MC; Östling P; Pietiäinen V; Price LS; Shorte SL; Turcatti G; von Schantz C; Carragher NO
    Nat Rev Drug Discov; 2016 Nov; 15(11):751-769. PubMed ID: 27616293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.